These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33398840)

  • 1. Optogenetics-Mediated Gene Therapy for Retinal Diseases.
    Tomita H; Sugano E
    Adv Exp Med Biol; 2021; 1293():535-543. PubMed ID: 33398840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Promoter Allows Optogenetic Vision Restoration with Enhanced Sensitivity in Macaque Retina.
    Chaffiol A; Caplette R; Jaillard C; Brazhnikova E; Desrosiers M; Dubus E; Duhamel L; Macé E; Marre O; Benoit P; Hantraye P; Bemelmans AP; Bamberg E; Duebel J; Sahel JA; Picaud S; Dalkara D
    Mol Ther; 2017 Nov; 25(11):2546-2560. PubMed ID: 28807567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selecting Channelrhodopsin Constructs for Optimal Visual Restoration in Differing Light Conditions.
    Ganjawala TH; Pan ZH
    Methods Mol Biol; 2021; 2191():189-199. PubMed ID: 32865746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal optogenetic therapies: clinical criteria for candidacy.
    Jacobson SG; Sumaroka A; Luo X; Cideciyan AV
    Clin Genet; 2013 Aug; 84(2):175-82. PubMed ID: 23590195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retinitis pigmentosa: eye sight restoration by optogenetic therapy].
    Roska B; Busskamp V; Sahel JA; Picaud S
    Biol Aujourdhui; 2013; 207(2):109-21. PubMed ID: 24103341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optogenetic Strategies for Vision Restoration.
    Lu Q; Pan ZH
    Adv Exp Med Biol; 2021; 1293():545-555. PubMed ID: 33398841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optogenetic Therapy for Visual Restoration.
    Sakai D; Tomita H; Maeda A
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bardet-Biedl Syndrome in rhesus macaques: A nonhuman primate model of retinitis pigmentosa.
    Peterson SM; McGill TJ; Puthussery T; Stoddard J; Renner L; Lewis AD; Colgin LMA; Gayet J; Wang X; Prongay K; Cullin C; Dozier BL; Ferguson B; Neuringer M
    Exp Eye Res; 2019 Dec; 189():107825. PubMed ID: 31589838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late gene therapy limits the restoration of retinal function in a mouse model of retinitis pigmentosa.
    Scalabrino ML; Thapa M; Wang T; Sampath AP; Chen J; Field GD
    Nat Commun; 2023 Dec; 14(1):8256. PubMed ID: 38086857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable phenotypic expressivity in inbred retinal degeneration mouse lines: A comparative study of C3H/HeOu and FVB/N rd1 mice.
    van Wyk M; Schneider S; Kleinlogel S
    Mol Vis; 2015; 21():811-27. PubMed ID: 26283863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual Responses of Photoreceptor-Degenerated Rats Expressing Two Different Types of Channelrhodopsin Genes.
    Sato M; Sugano E; Tabata K; Sannohe K; Watanabe Y; Ozaki T; Tamai M; Tomita H
    Sci Rep; 2017 Jan; 7():41210. PubMed ID: 28112267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved CoChR Variants Restore Visual Acuity and Contrast Sensitivity in a Mouse Model of Blindness under Ambient Light Conditions.
    Ganjawala TH; Lu Q; Fenner MD; Abrams GW; Pan ZH
    Mol Ther; 2019 Jun; 27(6):1195-1205. PubMed ID: 31010741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Ophthalmic Optogenetics: Approaches and Applications.
    Prosseda PP; Tran M; Kowal T; Wang B; Sun Y
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic approaches for retinitis pigmentosa].
    Pach J; Gekeler F
    Klin Monbl Augenheilkd; 2013 May; 230(5):512-8. PubMed ID: 23695848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bicistronic Construct for Optogenetic Prosthesis of Ganglion Cell Receptive Field of Degenerative Retina.
    Petrovskaya LE; Roshchin MV; Smirnova GR; Kolotova DE; Balaban PM; Ostrovsky MA; Malyshev AY
    Dokl Biochem Biophys; 2019 May; 486(1):184-186. PubMed ID: 31367817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functional characteristics of optogenetic gene therapy for vision restoration.
    Lindner M; Gilhooley MJ; Peirson SN; Hughes S; Hankins MW
    Cell Mol Life Sci; 2021 Feb; 78(4):1597-1613. PubMed ID: 32728765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoring vision using optogenetics without being blind to the risks.
    Harris AR; Gilbert F
    Graefes Arch Clin Exp Ophthalmol; 2022 Jan; 260(1):41-45. PubMed ID: 34724112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvaging ruins: reverting blind retinas into functional visual sensors.
    Mutter M; Swietek N; Münch TA
    Methods Mol Biol; 2014; 1148():149-60. PubMed ID: 24718800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early and late stage gene therapy interventions for inherited retinal degenerations.
    Botto C; Rucli M; Tekinsoy MD; Pulman J; Sahel JA; Dalkara D
    Prog Retin Eye Res; 2022 Jan; 86():100975. PubMed ID: 34058340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy restores vision and delays degeneration in the CNGB1(-/-) mouse model of retinitis pigmentosa.
    Koch S; Sothilingam V; Garcia Garrido M; Tanimoto N; Becirovic E; Koch F; Seide C; Beck SC; Seeliger MW; Biel M; Mühlfriedel R; Michalakis S
    Hum Mol Genet; 2012 Oct; 21(20):4486-96. PubMed ID: 22802073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.